Stereotactic Planning Software Market

By Solution Type;

Stand-alone Stereotactic Planning Solution, Integrated Stereotactic Planning Solution, and Services

By Imaging Modality;

CT Images, MR Images, and Angiographic Images

By Deployment Mode;

On-Premise and Cloud-Based

By Application;

Biopsy Planning, Deep Brain Stimulation (DBS), and Others

By End User;

Hospital, Ambulatory Surgical Centers, and Clinics

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn540492752 Published Date: June, 2025 Updated Date: August, 2025

Stereotactic Planning Software Market Overview

Stereotactic Planning Software Market (USD Million)

Stereotactic Planning Software Market was valued at USD 318.00 million in the year 2024. The size of this market is expected to increase to USD 435.66 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.6%.


Stereotactic Planning Software Market

*Market size in USD million

CAGR 4.6 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.6 %
Market Size (2024)USD 318.00 Million
Market Size (2031)USD 435.66 Million
Market ConcentrationHigh
Report Pages354
318.00
2024
435.66
2031

Major Players

  • Inomed Medizintechnik GmbH
  • Renishaw plc
  • Brainlab AG
  • Micromar Ind. Com. Ltda.
  • Elekta AB
  • Neurostar

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Stereotactic Planning Software Market

Fragmented - Highly competitive market without dominant players


The Stereotactic Planning Software Market is gaining momentum as neurosurgeons and radiation oncologists increasingly adopt precision-targeted planning tools for procedures like deep brain stimulation, lesion ablation, and radiosurgery. Nearly 65% of surgical centers now utilize planning software to enhance target accuracy and patient safety, driving heightened innovation and market expansion, supported by clinical–technology integration.

Technological Advancements Elevating Planning Accuracy
About 62% of software developers are enhancing platforms with features such as multimodal imaging fusion, AI‑driven trajectory optimization, real-time deformation modeling, and surgical navigation interface integration. These are transformative technological advancements that elevate procedural precision. Collaboration between neurosurgical teams and software engineers accelerates effective planning tool development.

Collaborative Adoption Ensuring Clinical Efficacy
Cross-disciplinary adoption initiatives among surgeons, radiologists, and academic institutions have led to a 59% increase in software use for stereotactic treatments. These cross-functional collaborations support training programs, standardized planning protocols, and system validation—contributing to growth through integrated clinical implementation.

Strategic Partnerships Unifying Technology and Care Networks
Approximately 63% of recent market progress is driven by strategic partnerships and joint ventures between software firms, surgical device makers, and hospital systems. These collaborations improve interoperability, streamline workflow integration, and enhance training support—fostering sustained market expansion and platform adoption.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Solution Type
    2. Market Snapshot, By Imaging Modality
    3. Market Snapshot, By Deployment Mode
    4. Market Snapshot, By Application
    5. Market Snapshot, By End User
    6. Market Snapshot, By Region
  4. Stereotactic Planning Software Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Machine Learning Algorithms

        2. Cloud-Based Platforms

        3. Interoperable Systems

        4. Improved Patient Outcomes

      2. Restraints
        1. High cost of implementation

        2. Concerns regarding data security and privacy

        3. Complex regulatory landscape

        4. Limited accessibility in certain regions

      3. Opportunities
        1. Remote Collaboration

        2. Patient-Centric Care

        3. Regulatory Harmonization

        4. Personalized Healthcare

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Stereotactic Planning Software Market, By Solution Type, 2021 - 2031 (USD Million)
      1. Stand-alone Stereotactic Planning Solution
      2. Integrated Stereotactic Planning Solution
      3. Services
    2. Stereotactic Planning Software Market, By Imaging Modality, 2021 - 2031 (USD Million)
      1. CT Images
      2. MR Images
      3. Angiographic Images
    3. Stereotactic Planning Software Market, By Deployment Mode, 2021 - 2031 (USD Million)

      1. On-Premise

      2. Cloud-Based

    4. Stereotactic Planning Software Market, By Application, 2021 - 2031 (USD Million)
      1. Biopsy Planning
      2. Deep Brain Stimulation (DBS)
      3. Others
    5. Stereotactic Planning Software Market, By End User, 2021 - 2031 (USD Million)
      1. Hospital
      2. Ambulatory Surgical Centers
      3. Clinics
    6. Stereotactic Planning Software Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Inomed Medizintechnik GmbH
      2. Renishaw plc
      3. Brainlab AG
      4. Micromar Ind. Com. Ltda.
      5. Elekta AB
      6. Neurostar
  7. Analyst Views
  8. Future Outlook of the Market